- Home
- FOLD vs BKE Comparison
FOLD vs BKE Comparison
Compare FOLD & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- BKE
- Stock Information
- Founded
- FOLD 2002
- BKE 1948
- Country
- FOLD United States
- BKE United States
- Employees
- FOLD N/A
- BKE N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- BKE Clothing/Shoe/Accessory Stores
- Sector
- FOLD Health Care
- BKE Consumer Discretionary
- Exchange
- FOLD Nasdaq
- BKE Nasdaq
- Market Cap
- FOLD 2.8B
- BKE 2.4B
- IPO Year
- FOLD 2007
- BKE 1992
- Fundamental
- Price
- FOLD $9.58
- BKE $48.17
- Analyst Decision
- FOLD Strong Buy
- BKE Hold
- Analyst Count
- FOLD 8
- BKE 1
- Target Price
- FOLD $17.00
- BKE $46.00
- AVG Volume (30 Days)
- FOLD 2.1M
- BKE 542.6K
- Earning Date
- FOLD 02-26-2025
- BKE 03-14-2025
- Dividend Yield
- FOLD N/A
- BKE 8.05%
- EPS Growth
- FOLD N/A
- BKE N/A
- EPS
- FOLD N/A
- BKE 3.94
- Revenue
- FOLD $493,671,000.00
- BKE $1,220,873,000.00
- Revenue This Year
- FOLD $34.33
- BKE N/A
- Revenue Next Year
- FOLD $21.70
- BKE $2.62
- P/E Ratio
- FOLD N/A
- BKE $12.39
- Revenue Growth
- FOLD 32.58
- BKE N/A
- 52 Week Low
- FOLD $8.79
- BKE $34.87
- 52 Week High
- FOLD $14.03
- BKE $54.25
- Technical
- Relative Strength Index (RSI)
- FOLD 50.06
- BKE 41.83
- Support Level
- FOLD $8.79
- BKE $47.03
- Resistance Level
- FOLD $9.63
- BKE $49.10
- Average True Range (ATR)
- FOLD 0.29
- BKE 1.39
- MACD
- FOLD 0.05
- BKE -0.38
- Stochastic Oscillator
- FOLD 90.48
- BKE 25.78
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to better-priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.